Sanofi (FRA:SNW2)

Market Cap	95.25B
Revenue (ttm)	45.74B
Net Income (ttm)	9.13B
Shares Out	n/a
EPS (ttm)	7.36
PE Ratio	10.44
Forward PE	9.66
Dividend	1.42 (3.69%)
Ex-Dividend Date	May 9, 2025

Volume	10
Average Volume	44
Open	38.40
Previous Close	39.60
Day's Range	38.40 - 38.40
52-Week Range	38.40 - 54.50
Beta	n/a
RSI	32.00
Earnings Date	Oct 24, 2025

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SNW2

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.